PTC Therapeutics
PTCT
#2687
Rank
C$8.56 B
Marketcap
C$106.73
Share price
-0.76%
Change (1 day)
57.27%
Change (1 year)

PTC Therapeutics (PTCT) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : C$3.86 Billion

According to PTC Therapeutics 's latest financial reports the company's total liabilities are C$3.86 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

PTC Therapeutics - Total liabilities on balance sheet (from 2012 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$4.02 B11.73%
2023-12-31C$3.60 B29.25%
2022-12-31C$2.78 B12.86%
2021-12-31C$2.46 B12.13%
2020-12-31C$2.20 B63.71%
2019-12-31C$1.34 B28.44%
2018-12-31C$1.04 B253.99%
2017-12-31C$0.29 B46.94%
2016-12-31C$0.20 B4.17%
2015-12-31C$0.19 B379.08%
2014-12-31C$40.32 M146.63%
2013-12-31C$16.35 M-49.04%
2012-12-31C$32.08 M-88.84%
2011-12-31C$0.28 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Vertex Pharmaceuticals
VRTX
C$10.42 B 169.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
C$3.00 B-22.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
C$0.15 B-96.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
C$0.34 B-91.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
C$0.33 B-91.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$86.39 B 2,133.90%๐Ÿ‡จ๐Ÿ‡ญ Switzerland